Research Article
Development and Validation of Stability Indicating RP-HPLC Method for Estimation of Satranidazole from Its Formulation
Table 3
Results of precision study.
| | Replicates | Method precision
Day-1
analyst-1
(% assay) | Intermediate precision
Day-2
analyst-2
(% assay) |
| | Assay-1 | 99.93 | 101.41 | | Assay-2 | 101.26 | 100.28 | | Assay-3 | 99.8 | 98.89 | | Assay-4 | 101.73 | 99.22 | | Assay-5 | 101.93 | 98.82 | | Assay-6 | 98.4 | 101.81 |
| | Average | 100.5083 | 100.0717 | | Standard deviation (SD) | 1.3682 | 1.30726 | | % relative standard deviation (% RSD) | 1.3612 | 1.3063 |
| | Average | 100.29 | | Standard deviation (SD) | 1.2960 | | % relative standard deviation (% RSD) | 1.2923 |
|
|
